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Introduction: Invasive aspergillosis is a serious complication in immunocompromised patients. It is an
opportunistic disease, which predominantly occurs in the lungs, although dissemination to virtually any organ is
possible. Invasive aspergillosis in an immunocompetent patient with extension to the mediastinum has rarely been
reported. Here, we present the case of a patient with no apparent immunodeficiency state, who presented with
Aspergillus endocarditis and fulminant invasive aspergillosis with extensive involvement of the mediastinal
structures, which ultimately was responsible for her death. To the best of our knowledge, this is the first reported
case in the literature on fulminant invasive mediastinal aspergillosis with extension to the pulmonary vasculature
and concomitant Aspergillus endocarditis in an apparently immunocompetent patient without pre-existing lung
disease.
Case presentation: Our patient was a previously healthy 47-year-old Asian woman, who presented to our
emergency room with severe progressive shortness of breath of one month’s duration, associated with orthopnea
and unstable vital signs.
Conclusion: Invasive aspergillosis has been described in the presence of pulmonary disease, such as chronic
obstructive pulmonary disorder, and one case has been reported in a patient without preexistent disease, but
none of these have been fatal. Our case is therefore the first reported case of its kind. Our case shows that
fulminant aspergillosis can occur in an immunocompetent host and can be fatal. We conclude that invasive
aspergillosis should not be excluded from the differential diagnosis on the basis of immunocompetency.Introduction
Invasive aspergillosis is a serious complication in im-
munocompromised patients. It is an opportunistic dis-
ease, which predominantly occurs in the lungs, although
dissemination to virtually any organ is possible. Invasive
aspergillosis in an immunocompetent patient with ex-
tension to the mediastinum has been reported rarely
[1-3]. Here, we present the case of a patient with no ap-
parent immunodeficiency with Aspergillus endocarditis
and fulminant invasive aspergillosis with extensive in-
volvement of the mediastinal structures, which ultim-
ately lead to the death of our patient.* Correspondence: samiaayub15@hotmail.com
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reproduction in any medium, provided the orCase presentation
This is a case history of a previously healthy non-
diabetic 47-year-old Asian woman, who presented to out
emergency room with severe progressive shortness of
breath of one month’s duration, associated with orthop-
nea. She was well-oriented but tachypneic, bradycardic
(30 beats/min) and hypotensive (70/60mmHg). Her ini-
tial management included fluid resuscitation, vasopres-
sors (norepinephrine and dopamine) and insertion of a
temporary pacemaker for the complete heart block evi-
denced by her initial electrocardiogram. Her physical
examination was unremarkable except for decreased air
entry in her right lower chest on auscultation. Her past
medical history was significant for an episode of syncope
due to complete heart block a year before but she con-
verted back to sinus rhythm without any intervention.
At that time, an echocardiogram revealed moderatel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chest X-ray showing mediastinal widening.
Figure 2 Chest computed tomography showing a right hilar mass inv
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with normal systolic function, and angiography showed
normal coronary arteries.
Her initial laboratory investigations were normal ex-
cept for marked leukocytosis (19.9 cells/mm3 with 70%
polymorpholeukocytes, 27% lymphocytes, 1% eosinophils
2% monocytes) and an elevated level of lactate dehydro-
genase (1240IU/L). She was started on broad-spectrum
antibiotics (piperacillin and tazobactam (ZosynW) and
vancomycin) after blood cultures were taken. A chest
X-ray was significant for mediastinal widening (Figure 1).
On further investigation, a computed tomography (CT)
scan of her chest revealed a large right-sided mediastinal
mass encasing her superior vena cava, ascending aorta,
pulmonary vessels and right main bronchus (Figures 2, 3).
A presumptive diagnosis of malignancy (likely lymphoma)
was made and our cardiothoracic surgery team performed
video-assisted thoracoscopic surgery to take a biopsy for
further confirmation of the diagnosis. A mass adherent to
the posterior surface of her sternum and fixed to herolving mediastinal structures.
Figure 3 Chest computed tomography showing a right hilar mass involving mediastinal structures.
Figure 4 Histology of the specimen showing fungal hyphae,
branched at acute angles.
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pathologic examination and cultures.
Later during the hospital course, she developed a
painful red eye, with decreased vision in her right eye.
This was evaluated by an ophthalmologist and diag-
nosed as endophthalmitis. An enzyme-linked immuno-
sorbent assay for human immunodeficiency virus (HIV)
was negative. The same day, she had chest pain with ST
elevation in the anterior leads on an electrocardiogram
(troponin 3.5ng/ml). Repeat echocardiography showed
an ejection fraction of 40%, a grossly dilated left atrium
and a moderately dilated right atrium. The basal and lat-
eral walls were akinetic and an echogenic density was
seen beneath the right septal leaflet. Later that night,
her Glasgow Coma Scale score dropped and she
required intubation to protect her airway. CT of her
head revealed a right frontotemporal region and basal
ganglia infarct. She went into cardiac arrest within a few
hours; despite advanced cardiac life support, she could
not be revived. An autopsy was refused.
The following day the biopsy report of the mediastinal
mass was finalized, and described it as a mass mainly
comprising necrotic tissue with abundant fungal spores
and hyphae. Hyphae were septated and branched at
acute angles (Figure 4). Unfortunately, the mold did not
grow in culture. The histopathology report was negative
for any underlying malignancy. Nevertheless, these find-
ings led to the diagnosis of a mediastinal mass due tofulminant invasive aspergillosis involving mediastinal
structures, and septic emboli as a complication of Asper-
gillus endocarditis.
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Aspergillus fumigatus is a common commensal of the
human airways and causes a broad spectrum of diseases,
ranging from hypersensitivity reactions to direct angioin-
vasion. The major forms of pulmonary aspergillosis
range from aspergilloma, with a relatively benign course,
to invasive aspergillosis, which has a rapidly progressive
course and is highly fatal [4]. Invasive aspergillosis more
commonly occurs in immunocompromised patients and,
especially in these patients with severe neutropenia,
transbronchial invasion can occur. The subsequent inva-
sion of the small pulmonary vessels, with hemorrhage
and pulmonary infarct, results in invasive pulmonary as-
pergillosis, which is responsible for a mortality rate as
high as 86%, even with treatment [5]. Rare cases with in-
volvement of the proximal pulmonary arteries, the heart
and the aorta have been reported in patients with inva-
sive aspergillosis, but to the best of our knowledge, a
case of fulminant invasive mediastinal aspergillosis in an
immunocompetent individual has never previously been
reported. The past medical history and laboratory work-
up (absence of neutropenia, normal blood sugar levels,
negative HIV status) and absence of any underlying ma-
lignancy (based on the computerized axial tomography
of her thorax and abdomen) support the immunocom-
petent status of our patient.
Reviewing our case in retrospect, our patient pre-
sented with a large mediastinal mass on a CT scan,
which was found through histopathology to be due to a
mold. Although the fungus did not grow in culture, the
morphology of acute angled septate hyphae point to-
wards Aspergillus species [6]. Regarding the diagnosis of
Aspergillus endocarditis, we do consider the fact that the
echogenic density (most likely a vegetation) in the right
septal leaflet of our patient’s valve was not proven
through histopathology to be due to a mold, but the
course of events are highly supportive of this. Other
clinical events that supported this diagnosis were the
embolic complications that are well-known in this dis-
ease entity. In our patient, the embolic manifestations
included endophthalmitis, cerebral infarction and myo-
cardial infarction. A strong association, up to 40%, has
been seen between fungal endophthalmitis and fungal
endocarditis, which emphasizes the importance of sus-
pecting fungal endocarditis in the setting of such ocular
disease [7]. Aspergillus endophthalmitis in an immuno-
competent person is rarely seen, and only one case has
been reported so far in the literature [8]. The rarity of
this presentation may have led to the delay in diagnosis.
According to a study conducted over five years and in-
cluding 152 cases of fungal endocarditis, therapeutic
interventions, such as intravascular catheter use and
valvular surgery, along with immunosuppressive treat-
ment, were the most common risk factors, although in3.4% of the total cases, no predisposing factor was iden-
tified [9]. Hence, this is possibly a unique case report of
invasive mediastinal aspergillosis and native valve fungal
endocarditis.
Several factors hamper the timely diagnosis of mold
endocarditis. The rarity of the syndrome coupled with
negative blood cultures seen in more than 90% of the
cases severely compromises the ability to secure an early
diagnosis and makes this a diagnostic challenge for
clinicians [10].
Conclusion
To the best of our knowledge, this is the first reported
case in the literature of fulminant invasive mediastinal as-
pergillosis with extension to the pulmonary vasculature
and concomitant Aspergillus endocarditis in an appar-
ently immunocompetent patient without preexisting lung
disease. Rarely, fulminant invasive mediastinal aspergil-
losis has been described in the presence of pulmonary
disease, such as chronic obstructive pulmonary disorder
[1,2], and one case has been reported in a patient without
preexisting lung disease [3], but none of these reported
cases has been fatal. Our case shows that fulminant asper-
gillosis can occur in an immunocompetent host and can
result in the death of the patient. Therefore, invasive as-
pergillosis should not be excluded from the differential
diagnosis on the basis of immunocompetency.
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